More stories

  • in

    Ex-White House lawyer endured 'some crazy shit' from Trump, book reveals

    Former White House counsel Don McGahn endured screaming matches with Donald Trump, badgering phone calls at home on his birthday and the president saying “some crazy shit” in order to advance the project closest to McGahn’s heart: packing the federal judiciary with activist conservative judges.McGahn’s lead role in developing the roster of judges used by Trump to remake the federal judiciary – Trump has elevated 201 judges and counting, including two supreme court justices – has long been known.But a new book by the New York Time reporter Michael Schmidt reveals for the first time the trials that McGahn, a libertarian who saw extreme judges as the best way to limit the scope of government, underwent to take advantage of the “once-in-a-never-again” opportunity he had in the chaotic early days of the Trump White House.The book, Donald Trump v The United States: Inside the Struggle to Stop a President, a copy of which was obtained by the Guardian, hits bookstores next week.In the book Schmidt, who originally broke the news that McGahn had cooperated extensively with special counsel Robert Mueller in the investigation of the Trump campaign’s Russia ties, deepens the picture of that cooperation. “McGahn had turned into the Mueller team’s personal Forrest Gump,” Schmidt writes, “the guy with the front-row seat to all the awful history of the Trump administration he had never wanted to witness.”Schmidt’s book focuses on the roles McGahn and former FBI director James Comey played in attempting to contain a president both men recognized as mercurial and potentially threatening to the country.Comey was fired by Trump in May 2017, leading to the appointment of Mueller, one of many dramatic developments in Trump’s first term that Schmidt was on the vanguard of reporting at the time. Schmidt recounts that episode and many others with new details, to dramatic effect, in the book.McGahn left the White House in October 2018, after the successful confirmation of the man McGahn personally picked as Trump’s second supreme court justice, Brett Kavanaugh.While not seeming to share Comey’s anguished concern for the independence of the judiciary and the balance of powers under Trump, McGahn – a campaign law expert – had plenty of personal frustration with Trump, whom he referred to as “Kong” or “King Kong” or “fucking Kong”, after the hostile movie gorilla, Schmidt reports.The Mueller report previously documented McGahn’s run-ins with his boss. One of the key descriptions of potential obstruction of justice by Trump in the report describes Trump calling McGahn at home and instructing McGahn to put in motion Mueller’s firing, an instruction McGahn ignored apart from relaying it to his personal lawyer.But Schmidt reveals the previously unknown extent to which McGahn cooperated with Mueller, turning over “nearly a thousand pages of handwritten White House notes” to the special counsel. The cooperation was so fruitful, Schmidt writes, that Mueller’s team tried to “run” McGahn, or recruit him to gather information in real time about what was happening inside the White House. No such arrangement was explicitly made.Much of the book expands on major scoops by Schmidt during the special counsel’s investigation, including the revelations that then attorney general Jeff Sessions was looking for dirt on Comey; that Trump had moved to fire Mueller; and scenes such as Trump’s explosion upon learning that deputy attorney general Rod Rosenstein had appointed Mueller as special counsel: “It’s your fucking fault!” Trump thundered at Sessions.On multiple occasions, Schmidt writes, McGahn prepared his resignation as White House counsel, whose role is to give the president legal advice as it relates to the office of the presidency.McGahn prepared a one-line resignation letter after the White House came under pressure to withdraw Trump’s first nomination to the US supreme court, Neil Gorsuch, whom McGahn also had personally picked, according to the book.“Nominating judges was why he had taken the job,” Schmidt writes. “He was told this was going to be his turf, entirely.”Later, after Trump called him at home on his birthday – twice – and told him to tell Rosenstein to fire Mueller, McGahn went so far as to clean out his office at the White House and prepare another letter.“I have a real fucking problem,” McGahn told his personal lawyer about Trump, according to Schmidt. “I don’t want to speak out of school, but he’s saying some crazy shit.”But the resignation letter was never sent. The greater project, for McGahn, of appointing judges, as well as slashing government regulations, held precedence.Schmidt writes: “McGahn knew that he would never have this power again.” More

  • in

    Trump’s presidential powers on full display at day two of RNC – video report

    Play Video

    2:10

    Ethical questions were raised during day two of the Republican national convention, as Donald Trump was accused of misusing trappings of his office for political purposes and using the White House as a prop. 
    Pardoning convicts, naturalisation ceremonies and speeches from the White House were just a few of the items on the agenda that caused concern. 
    Culture wars and a pitch to women: key takeaways from night two of the RNC

    Topics

    US news

    Republican national convention 2020

    Donald Trump

    Trump administration

    US elections 2020

    Republicans

    US politics More

  • in

    Melania Trump addresses Covid death toll, calls for unity amid racial tensions in RNC speech – video

    Play Video

    2:27

    US first lady Melania Trump bucked the attacking trend of the 2020 Republican national convention speeches, addressing the country’s large coronavirus death toll and calling for unity amid growing racial tension. The speech shifted the tone on an evening spent criticising the policies of Democratic rivals including Joe Biden. Melania Trump’s speech was the third of the evening from the president’s family, following addresses from daughter Tiffany and son Eric
    Culture wars and a pitch to women: key takeaways from night two of the RNC
    Melania Trump offers condolences to families of Covid-19 victims in RNC speech

    Topics

    Donald Trump

    Republican national convention 2020

    Republicans

    Trump administration

    US politics More

  • in

    Melania Trump taped making derogatory remarks about Donald and Ivanka – report

    Melania Trump will speak at the Republican national convention on Tuesday night, in the shadow of an extraordinary report that she was taped making derogatory comments about her husband’s adult children and even Donald Trump himself.On Monday the media reporter Yashar Ali cited unnamed sources in reporting that Stephanie Winston Wolkoff, a former friend and adviser, “taped the first lady” and plans to share the remarks in her book.They include “harsh comments about Ivanka Trump, the president’s elder daughter and a senior adviser”, Ali wrote.Melania & Me is out on 1 September.The US continues to digest the publication, by the Washington Post, of tapes of Donald Trump’s older sister, Maryanne Trump Barry, calling the president “cruel” and criticizing his character and behavior.Those tapes were made surreptitiously but legally by Mary L Trump, the president’s niece, who released a bestselling book in July, Too Much and Never Enough: How My Family Created the World’s Most Dangerous Man.Simon & Schuster published Mary Trump’s book and one by John Bolton, Trump’s former national security adviser. It will publish Melania & Me.In publicity material, the publisher says Wolkoff, a long-term friend of Melania Trump “was recruited to help produce the 58th presidential inaugu­ration and to become the first lady’s trusted adviser”.“… Then it all fell apart when she was made the scapegoat for inauguration finance irregularities. Melania could have defended her innocent friend and confidant, but she stood by her man, knowing full well who was really to blame. The betrayal nearly destroyed Wolkoff.”Fundraising for Trump’s inauguration has been the subject of investigations by the special counsel and authorities in New York, New Jersey and the District of Columbia, which alleged fundraising was used to enrich Trump family members.The White House did not immediately comment on reports about Wolkoff’s book but last weekend, responding to his sister’s comments, the president indicated he has grown used to such news.“Every day it’s something else,” Trump said. “Who cares?”Evidently, publishing companies do. Melania & Me is the latest in a stream of tell-alls due out before the election in November. The former personal lawyer Michael Cohen and former campaign aide Rick Gates – both convicted in cases arising from the work of special counsel Robert Mueller, Gates a figure in the inauguration case – have books on the way. So does the former Mueller prosecutor Andrew Weissmann.HR McMaster, national security adviser before Bolton, has a memoir coming out this month. The Watergate reporter Bob Woodward also has a new Trump book coming.Melania has been the subject of previous books including Free, Melania by Kate Bennett and Melania: The Art of Her Deal by Mary Jordan.From Wolkoff, Simon & Schuster promises a “candid and emotional memoir” which will answer questions about many of the most scandalous and salacious moments of the Trump presidency. Among them: “How did Melania react to the Access Hollywood tape” – in which Donald Trump infamously boasted of grabbing women “by the pussy” – “and her husband’s affair with Stormy Daniels”, which Trump denies but which remains a cause of legal trouble and political jeopardy.“Does she get along well with Ivanka?” the publisher asks. “Why did she wear that jacket with ‘I really don’t care, do u?’ printed on the back? Is Melania happy being first lady?“And what really happened with the inauguration’s funding of $107m? Wolkoff has some ideas …” More

  • in

    Oleandrin: Trump allies pitch extract from poisonous plant to fight Covid

    Allies of Donald Trump have promoted a plant extract called oleandrin to people seeking to ward off Covid-19. The plant the extract is derived from, oleander, is poisonous and there is no proof the compound is either safe or effective to treat or prevent Covid-19, experts say.But unlike other unproven and potentially dangerous Covid-19 “cures” pitched by Donald Trump and his supporters, including the prescription antimalarial hydroxychloroquine, experts fear this compound could easily reach the public as a dietary supplement.“Supplements are like snake oil, in the sense they are not regulated by the FDA,” said Martin Ronis, a professor in Louisiana State University’s department of pharmacology and experimental therapeutics, referring to the US Food and Drug Administration.While pharmaceutical companies must show the FDA drugs are safe before they go to market, dietary supplements are considered “food” in the US and thus must be proven unsafe before they are removed from the market. Because of this regulatory structure, Ronis said it would be possible for the company behind the plant compound – Texas-based Phoenix Biotechnology – to bring the extract to market.“You can essentially make all kinds of apocryphal claims about supplements,” said Ronis. One of Phoenix’s board members is Mike Lindell, a prominent Trump backer, pitchman, and CEO of MyPillow. Lindell chairs Trump’s re-election effort in Minnesota.While Lindell has pitched Phoenix’s plant extract as a coronavirus cure on TV and to the president’s coronavirus taskforce, the company also quietly received $5m in funding from an undisclosed investor, patented its extract for use in Covid-19, and promoted an early study in monkey cells as proof of efficacy – an assertion one of the study’s own authors denies.Lindell told the TV host Greg Kelly, an anchor on the conservative Newsmax network: “I started using it myself and giving it to friends and family who tested positive.”The interview was one of several television appearances about oleandrin and is prominently displayed on the company’s website. “Is he allowed to do that?” Kelly laughed as he asked his other guest, Andrew Whitney, the vice-chairman and fellow director of Phoenix Biotechnology.“Well, I’m doing it as well,” Whitney replied, “and so is everyone else at the company, because we believe in the product, Greg. We know it works.” Phoenix Biotechnology did not respond to an emailed request for an interview.The Washington Post has reported that Whitney has visited Trump in the White House and pitched oleandrin to him.Oleandrin has not been approved to treat any medical disorder. The supplements industry has also opposed introducing oleandrin to the market.“The unanimous opinion is that this is a stupid idea and no one should allow an oleander supplement to get close to their mouth,” ​said Loren Israelsen, president of the United Natural Products Alliance, in a statement to a trade publication.Phoenix Biotechnology has released only one study on oleandrin’s use against Covid-19. The study was published in what is called a “pre-print”, which means it is not peer-reviewed. Two of the authors had a financial stake in Phoenix Biotechnology. The study, called an “in vitro” study, examined oleandrin’s effect on monkey cells in the laboratory.Pharmaceutical companies looking for FDA approval typically take drugs through a long pipeline of testing including in pre-clinical trials, in non-human primates, and then in a series of clinical trials testing for safety and dosing, leading up to a double-blind, placebo-controlled randomized trial for efficacy.If Phoenix sought approval for its product, the pre-print it published would represent a concept for potential study at the very beginning of this pipeline. The median cost of bringing a drug to market is $985m, according to a recent study in the Journal of the American Medical Association. Most new drugs fail.Phoenix has conducted two clinical trials for safety of oleandrin in cancer treatment, but both were small. Phoenix proposed providing oleandrin in what appears to be a liquid, according to its website.Although Whitney said in his interview with Kelly that Phoenix has researched oleandrin for “25 years”, the earliest research related to the company appears to be from 2002. Phoenix was incorporated in 2003, according to a press release.Phoenix received a patent for its extraction process in 2005, and in that time it has sponsored research at several institutions, including University of Texas San Antonio, the MD Anderson Cancer Center and Duke University.The company appears to be moving ahead in its efforts to monetize oleandrin. The “pre-print” was published on 15 July. The company filed for patents in the US on 18 July and earlier in Australia. The American patent was reportedly granted on 29 July, and Phoenix told the US Securities and Exchange Commission it received $5m from a single, unnamed investor on 7 August. More